Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Cy3 NHS Ester (Non-Sulfonated): The Gold Standard for Pro...

    2025-11-08

    Cy3 NHS Ester (Non-Sulfonated): The Gold Standard for Protein and Organelle Labeling

    Principle Overview: Precision Fluorescent Dye for Amino Group Labeling

    Cy3 NHS ester (non-sulfonated) is a member of the cyanine dye family, engineered for high-sensitivity labeling of primary amines in biomolecules—including proteins, peptides, and oligonucleotides. Its core strength lies in its robust polymethine structure, yielding broad spectral coverage and a distinctive orange fluorescence (excitation: 555 nm, emission: 570 nm). This property ensures compatibility with standard TRITC filter sets, making it a preferred fluorescent dye for amino group labeling in advanced biomedical imaging and biochemical assays.

    The dye's high extinction coefficient (150,000 M⁻¹cm⁻¹) and quantum yield (0.31) translate to bright, photostable signals suitable for quantitative imaging and single-molecule detection. As detailed on the Cy3 NHS ester (non-sulfonated) product page, its solubility profile (≥59 mg/mL in DMSO, ≥25.3 mg/mL in ethanol) makes it ideal for both standard and high-load labeling protocols. However, users must note its insolubility in water, necessitating organic co-solvents such as DMF or DMSO for optimal conjugation efficiency.

    Step-by-Step Workflow: Protocol Enhancements for Maximum Labeling Efficiency

    1. Sample Preparation

    • Buffer Exchange: Prior to labeling, ensure that target biomolecules (proteins, peptides, or oligonucleotides) are desalted into an amine-free buffer (e.g., 0.1 M sodium bicarbonate, pH 8.3) to eliminate primary amine contaminants that would compete with the intended labeling reaction.
    • Concentration Adjustment: Adjust sample concentration to 1–10 mg/mL for proteins, or 100–500 µM for peptides/oligonucleotides for optimal reaction stoichiometry.

    2. Dye Dissolution and Reaction Setup

    • Dye Dissolution: Dissolve Cy3 NHS ester (non-sulfonated) in anhydrous DMSO or DMF to a stock concentration of 10 mM. Use ultrasonic agitation if preparing concentrated stocks in ethanol.
    • Labeling Reaction: Add the dye solution to the biomolecule at a 5–10-fold molar excess. Incubate at room temperature for 30–60 minutes in the dark. For proteins sensitive to organic co-solvents, limit DMSO/DMF final concentration to ≤10% v/v to maintain structural integrity.

    3. Purification and Quality Control

    • Purification: Remove unreacted dye using size-exclusion chromatography, spin columns, or dialysis (for large proteins/complexes). For peptides and oligonucleotides, reverse-phase HPLC is recommended for purity assessment.
    • Degree of Labeling (DOL): Quantify DOL by measuring absorbance at 280 nm (protein) and 555 nm (Cy3). Utilize the dye's extinction coefficient to calculate the labeling ratio—typically, a DOL of 1–3 dyes per protein is optimal for imaging without quenching.

    4. Storage and Handling

    • Storage: Store lyophilized conjugates at -20°C in the dark. Avoid repeated freeze-thaw cycles. For short-term storage, aliquot labeled biomolecules in buffer containing 50% glycerol and protect from light.

    Advanced Applications and Comparative Advantages

    Empowering Targeted Organelle Degradation Assays

    Cy3 NHS ester (non-sulfonated) is pivotal in workflows that require precise visualization of biomolecules in complex systems. A prime example is its utility in nanoparticle-based organelle degradation platforms, such as the modular NanoTACOrg system described in Yuai Li et al., ACS Nano (2025). By labeling organelle-targeting or autophagy-adaptor proteins with Cy3, researchers can monitor aggregate formation, trafficking, and autophagosome recruitment in real-time, enabling quantitative studies of selective autophagy and metabolic reprogramming in cancer therapy.

    Compared to water-soluble sulfo-Cy3 NHS esters, the non-sulfonated Cy3 NHS ester offers enhanced membrane permeability and broader compatibility with hydrophobic nanoparticle assemblies. This is particularly advantageous for in vitro reconstitution of multivalent aggregates or for labeling constructs intended for cellular uptake. As highlighted in the article "Cy3 NHS Ester (Non-Sulfonated): Illuminating the Next Frontier of Biomedical Imaging", the dye's robust fluorescence and compatibility with diverse labeling strategies set it apart in translational research applications.

    High-Sensitivity Imaging in Biomedical Research

    With its orange-shifted emission and high quantum yield, Cy3 NHS ester (non-sulfonated) is ideal for multiplexed fluorescence microscopy, flow cytometry, and in-gel detection. Its spectral characteristics minimize overlap with common green (FITC) and red (Cy5) channels, supporting multi-color imaging of cellular processes such as organelle degradation, protein trafficking, and cell signaling dynamics. As described in "Cy3 NHS Ester (Non-Sulfonated): Precision Fluorescent Dye for Next-Gen Imaging", this specificity underpins its growing adoption in advanced proteomics and single-cell studies.

    Complementary and Extending Resources

    Troubleshooting and Optimization Tips

    • Low Labeling Efficiency: Ensure proteins or peptides are buffer-exchanged into amine-free buffers. Residual Tris, glycine, or ammonium ions can compete with target biomolecules for dye conjugation. Adjust pH to 8.3–8.5 for optimal NHS ester reactivity.
    • Protein Precipitation: Minimize DMSO or DMF content when labeling sensitive proteins. For delicate biomolecules, consider rapid dilution into aqueous buffers post-labeling or use sulfo-Cy3 NHS esters if organic co-solvents must be avoided.
    • Excess Background Fluorescence: Remove unreacted dye thoroughly using size-exclusion columns or HPLC. Incomplete purification is a common source of high background in imaging assays.
    • Photobleaching: Shield samples from light during and after the labeling process. Incorporate anti-fade agents in storage and imaging buffers to preserve signal during extended microscopy sessions.
    • Batch-to-Batch Variability: Standardize reaction stoichiometry and incubation times. Always calculate degree of labeling for each batch to ensure reproducibility and comparability across experiments.

    Future Outlook: Expanding the Potential of Cy3 NHS Ester (Non-Sulfonated)

    The strategic use of Cy3 NHS ester (non-sulfonated) is poised to grow as next-generation nanoparticle assemblies and synthetic organelle mimics become integral to precision medicine. With the evolution of multivalent targeting platforms such as NanoTACOrg (see ACS Nano, 2025), fluorescent labeling will continue to play a central role in decoding the spatial and temporal dynamics of subcellular processes.

    Emerging integrations with automated microfluidics, high-content screens, and artificial intelligence-driven image analysis promise to further amplify the impact of Cy3 NHS ester (non-sulfonated) in biomedical discovery. Enhanced variants, such as sulfo-Cy3 for aqueous protocols, will complement the non-sulfonated form, ensuring that researchers can tailor their labeling strategies to any biomolecule, organelle, or system of interest. For those seeking to push the boundaries of quantitative imaging, targeted degradation, and translational innovation, Cy3 NHS ester (non-sulfonated) remains a foundational tool.